Inflammatory bone marrow microenvironment
Open accessAbstract
Self-renewing hematopoietic stem cells and their progeny, lineage-specific downstream progenitors, maintain steady-state hematopoiesis in the bone marrow (BM). Accumulating evidence over the last few years indicates that not only primitive hematopoietic stem and progenitor cells (HSPCs), but also cells defining the microenvironment of the BM (BM niche), sense hematopoietic stress signals. They respond by directing and orchestrating hematopoiesis via not only cell-intrinsic but also cell-extrinsic mechanisms. Inflammation has many beneficial roles by activating the immune system in tissue repair and as a defense mechanism. However, chronic inflammation can have detrimental effects by stressing HSPCs, leading to cell (DNA) damage resulting in BM failure or even to leukemia. Emerging data have demonstrated that the BM microenvironment plays a significant role in the pathogenesis of hematopoietic malignancies, in particular, through disrupted inflammatory signaling, specifically in niche (microenvironmental) cells. Clonal selection in the context of microenvironmental alterations can occur in the context of toxic insults (eg, chemotherapy), not only aging but also inflammation. In this review, we summarize mechanisms that lead to an inflammatory BM microenvironment and discuss how this affects normal hematopoiesis. We pay particular attention to the process of aging, which is known to involve low-grade inflammation and is also associated with age-related clonal hematopoiesis and potentially malignant transformation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 85 cited sources checked · 0 supported · 0 flagged
- Findingown data
Increased expression of S100A8 in MDS-derived macrophages induces S100A8 expression in neighboring MSCs.
“Using an MDS mouse model and patient samples, we demonstrated that increased expression of S100A8 in MDS-derived macrophages induces S100A8 expression in neighboring MSCs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ribezzo, 2019, Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome, Leukemia source
Not checked in the free run.
- Findingcitation
Rps14 haploinsufficiency in a murine model of del(5q) MDS leads to increased expression of S100A8 and S100A9 in mutant erythroblasts, monocytes, and macrophages, the main regulatory cells of the erythroid niche.
“In our previous work, we demonstrated that Rps14 haploinsufficiency in a murine model of del(5q) MDS leads to increased expression of S100A8 and S100A9 in mutant erythroblasts, monocytes, and macrophages, the main regulatory cells of the erythroid niche.70”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ribezzo, 2019, Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome, Leukemia source
Not checked in the free run.
- Findingcitation
Increased expression of S100A8 in stromal cells is directly linked to loss of their hematopoiesis-supporting capacity.
“We further directly linked the increased expression of S100A8 in stromal cells to loss of their hematopoiesissupporting capacity.70”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ribezzo, 2019, Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome, Leukemia source
Not checked in the free run.
- Findingcitation
Increased expression of S100A8/S100A9 was observed in the mesenchymal niche in del(5q) MDS.
“Interestingly, we also observed increased expression of S100A8/S100A9 in the mesenchymal niche in del(5q) MDS.70”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ribezzo, 2019, Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome, Leukemia source
Not checked in the free run.
- Premisecitation
Osteoblastic lineage cells (OBCs) express various factors important for HSC function.
“As an example, osteoblastic lineage cells (OBCs) express various factors important for HSC function (Winkler et al 7 and Schepers et al 8 ).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Winkler et al 7
Not checked in the free run.
- cites Schepers et al 8
Not checked in the free run.
- Interpretationnone given
The bone marrow microenvironment plays a significant role in the pathogenesis of hematopoietic malignancies, particularly through disrupted inflammatory signaling in niche cells.
“Emerging data have demonstrated that the BM microenvironment plays a significant role in the pathogenesis of hematopoietic malignancies, in particular, through disrupted inflammatory signaling, specifically in niche (microenvironmental) cells.”
Quote in the paperSubstantial claim - Premisecitation
BM mesenchymal stromal cells (BM-MSCs) are a rare population of cells in proximity to arterioles and sinusoid vessels (perivascular niche) or in proximity to the bone (endosteal niche).
“BM mesenchymal stromal cells (BM-MSCs) are a rare population of cells in proximity to arterioles and sinusoid vessels (perivascular niche) or in proximity to the bone (endosteal niche).6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] El Agha, 2017, Mesenchymal stem cells in fibrotic disease, Cell Stem Cell source
Not checked in the free run.
- Premisecitation
Dysfunction of the interaction between HSPCs and distinct stem cell niche populations in malignant hematopoietic diseases or inflammatory processes disrupts the tight regulation of hematopoiesis and favors a secretory phenotype of microenvironmental cells leading to impaired hematopoiesis-supporting capacity.
“Evidence over the last years indicates that a dysfunction of the interaction between hematopoietic stem and progenitor cells (HSPCs) and distinct stem cell niche populations either in malignant hematopoietic diseases or also in inflammatory processes disrupts the tight regulation of hematopoiesis and favors a secretory phenotype of microenvironmental cells leading to impaired hematopoiesis-support”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Kramann, 2018, The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis, Blood source
Not checked in the free run.
- cites [2] Gleitz, 2018, Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis, J Pathol source
Not checked in the free run.
- Premisecitation
IFN-g is produced during acute infections and leads to activation and proliferation of otherwise quiescent HSCs to immunologically fight pathogens.
“IFN-g, a prominent type II interferon, is produced during acute infections and leads to an activation and proliferation of otherwise quiescent HSCs to immunologically fight pathogens.20”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Baldridge, 2010, Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection, Nature source
Not checked in the free run.
- Premisecitation
Endothelial cells are part of the perivascular HSC niche.
“Endothelial cells themselves are also a part of the perivascular HSC niche.13”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Perlin, 2017, Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment, J Mol Med (Berl) source
Not checked in the free run.
- Interpretationnone given
Chronic inflammation can have detrimental effects by stressing HSPCs, leading to cell (DNA) damage resulting in bone marrow failure or leukemia.
“However, chronic inflammation can have detrimental effects by stressing HSPCs, leading to cell (DNA) damage resulting in BM failure or even to leukemia.”
Quote in the paperSubstantial claim - Premisecitation
IFN-g mainly affects the self-renewal and repopulating capacity of hematopoietic progenitors by moderating their response to other cytokines, mediated by STAT1 and SOCS1 and SOCS3.
“IFN-g mainly affects the self-renewal and repopulating capacity of hematopoietic progenitors by moderating their response to other cytokines.23 This effect is mainly mediated by STAT1 and suppressor of cytokine signaling 1 (SOCS1) and SOCS3 as effector molecules.21,24”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [23] Ishihara, 2014, Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3, Int J Hematol source
Not checked in the free run.
- cites [21] de Bruin, 2014, Impact of interferon-γ on hematopoiesis, Blood source
Not checked in the free run.
- cites [24] de Bruin, 2012, IFNγ induces monopoiesis and inhibits neutrophil development during inflammation, Blood source
Not checked in the free run.
- Interpretationnone given
Clonal selection in the context of microenvironmental alterations can occur in the context of toxic insults (eg, chemotherapy), aging, and inflammation.
“Clonal selection in the context of microenvironmental alterations can occur in the context of toxic insults (eg, chemotherapy), not only aging but also inflammation.”
Quote in the paperSubstantial claim - Premisecitation
Chronic exposure to IFN-g functionally impairs HSCs in vitro and in vivo, particularly when secreted by stromal cells within the hematopoietic niche.
“Chronic exposure, however, functionally impairs HSCs in vitro and in vivo, 21 in particular when secreted by stromal cells within the hematopoietic niche.22”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [21] de Bruin, 2014, Impact of interferon-γ on hematopoiesis, Blood source
Not checked in the free run.
- cites [22] Selleri, 1996, Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition, Blood source
Not checked in the free run.
- Interpretationnone given
Not only primitive hematopoietic stem and progenitor cells (HSPCs), but also cells defining the bone marrow microenvironment sense hematopoietic stress signals and respond by directing and orchestrating hematopoiesis via cell-intrinsic and cell-extrinsic mechanisms.
“Accumulating evidence over the last few years indicates that not only primitive hematopoietic stem and progenitor cells (HSPCs), but also cells defining the microenvironment of the BM (BM niche), sense hematopoietic stress signals.They respond by directing and orchestrating hematopoiesis via not only cellintrinsic but also cell-extrinsic mechanisms.”
Quote in the paperSubstantial claim - Premisenone given
IL-6 secreted by MSCs can induce an anti-inflammatory phenotype in macrophages.
“IL-6, also secreted by MSCs, can induce an anti-inflammatory phenotype in macrophages.”
Quote in the paperNot a substantial claim - Premisecitation
Sustained IFN-a/g activation during chronic infection impairs HSC function ultimately leading to BM failure.
“The best-studied example is sustained IFN-a/g activation during chronic infection, which impairs HSC function ultimately leading to BM failure.43”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Morales-Mantilla, 2018, The role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease, Curr Stem Cell Rep source
Not checked in the free run.
- Premisecitation
Aged HSCs transplanted into a young BM environment exhibit less characteristics associated with senescent hematopoiesis.
“The relevance of niche interaction and signaling is highlighted by the fact that aged HSCs transplanted into a young BM environment exhibit less characteristics associated with senescent hematopoiesis.49”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] Ergen, 2012, Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing, Blood source
Not checked in the free run.
- Premisecitation
MSCs play a role in innate and acquired immunity directly through cell-cell contact or secretion of soluble factors.
“MSCs play a role in innate and acquired immunity directly through cell-cell contact or secretion of soluble factors.32,33”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [32] Lamble, 2018, Targeting the immune microenvironment in acute myeloid leukemia: a focus on T cell immunity, Front Oncol source
Not checked in the free run.
- cites [33] Wang, 2014, Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications, Nat Immunol source
Not checked in the free run.
- Premisecitation
Type I IFNs are involved in the development of AA.
“Although the pathogenesis is still not entirely understood, type I IFNs have been identified to be involved in the development of AA. 55”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Zoumbos, 1985, Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo, Proc Natl Acad Sci USA source
Not checked in the free run.
- Interpretationreasoning
Inflammatory processes in AA predominantly affect HSCs and not the stromal cells.
“It is important to note that the inflammatory processes in AA predominantly affect HSCs and not the stromal cells.”
Quote in the paperSubstantial claim - Premisecitation
Stromal cells isolated from aplastic BM have the capacity to form a functional hematopoietic microenvironment in vivo.
“Stromal cells isolated from aplastic BM have the capacity to form a functional hematopoietic microenvironment in vivo.58”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Michelozzi, 2017, Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo, Br J Haematol source
Not checked in the free run.
- Premisecitation
Loss of the vascular-endothelial-expressed Notch ligand DLL4 skews HSPC differentiation toward myelopoiesis.
“They particularly showed that the loss of the vascular-endothelial-expressed Notch ligand DLL4 skews HSPC differentiation toward myelopoiesis.42”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Tikhonova, 2019, The bone marrow microenvironment at single-cell resolution, Nature source
Not checked in the free run.
- Premisecitation
The SASP is most likely initiated by aging/senescent cells producing IL-1a in the microenvironment.
“The SASP is most likely initiated by aging/senescent cells producing IL-1a in the microenvironment.46”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Orjalo, 2009, Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
A frequent observation is the natural replacement of hematopoietic BM with adipose tissue in the elderly.
“A frequent observation is the natural replacement of hematopoietic BM with adipose tissue in the elderly.50”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Tuljapurkar, 2011, Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging, J Anat source
Not checked in the free run.
- Premisecitation
The accumulation of myeloid-skewed HSCs in aging is mediated by activated signaling of TLR4, P-selectin, NF-kB, RANTES-mTOR, and TGF-b.
“The accumulation of myeloid-skewed HSCs in aging is mediated by activated signaling of TLR4, P-selectin, NF-kB, RANTES-mammalian target of rapamycin (mTOR), and transforming growth factor-b (TGF-b).”
Quote in the paperSubstantial claim - Premisecitation
Indirect effects of IFN-g on macrophages and MSCs contribute to high levels of accessory inflammatory cytokines like IL-6, IL-1b, and TNF-a.
“Indirect effects of IFN-g on macrophages and MSCs have been implied to contribute to high levels of accessory inflammatory cytokines like IL-6, IL-1b, and TNF-a.57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Chen, 2013, Expression level of IL-6 secreted by bone marrow stromal cells in mice with aplastic anemia, ISRN Hematol source
Not checked in the free run.
- Premisenone given
Signaling through TLRs, TNF, and IL-1 negatively influences the long-term potential of HSCs through activation of apoptosis or induction of myeloid differentiation.
“Signaling through TLRs, TNF, and interleukin 1 (IL-1) negatively influences the long-term potential of HSCs through activation of apoptosis or induction of myeloid differentiation.”
Quote in the paperSubstantial claim - Premisecitation
Chronic TNF-a signaling is linked to development of myelodysplastic syndrome (MDS) and BM failure.
“Along the same line, chronic TNF-a signaling was linked to development of myelodysplastic syndrome (MDS) and BM failure.44”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Lambert, 2016, Bone marrow immunity and myelodysplasia, Front Oncol source
Not checked in the free run.
- Premisecitation
High levels of PU.1 cause a restriction of MPPs to granulocytic, monocytic, and lymphoid differentiation at the cost of megakaryocyte and erythroid differentiation.
“High levels of PU.1 cause a restriction of MPPs to granulocytic, monocytic, and lymphoid differentiation at the cost of megakaryocyte and erythroid differentiation, thus not only affecting erythroid differentiation but also myeloid cells.28”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Arinobu, 2007, Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages, Cell Stem Cell source
Not checked in the free run.
- Interpretationcitation
A sustained inflammatory response might ultimately have detrimental effects on hematopoiesis, resulting in bone marrow failure or hematopoietic malignancies.
“Importantly, a sustained inflammatory response might ultimately have detrimental effects on hematopoiesis, resulting in, for example, BM failure or even hematopoietic malignancies.”
Quote in the paperSubstantial claim - Premisecitation
Upon TLR stimulation, MSCs can induce migration of monocytes from the BM by expressing CCL2/MCP1.
“Upon TLR stimulation, MSCs can induce the migration of monocytes from the BM by expressing the monocyte-recruiting chemokine, CCL2 also known as MCP1.[35][36][37]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35][36][37]
Not checked in the free run.
- Premisecitation
In elderly patients, a systemic abundance of proinflammatory cytokines (IL-1, TNF, and IL-6) can be detected, called senescence-associated secretory phenotype (SASP).
“In elderly patients, a systemic abundance of proinflammatory cytokines (IL-1, TNF, and IL-6) can be detected, which is called senescence-associated secretory phenotype (SASP).45”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Coppé, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu Rev Pathol source
Not checked in the free run.
- Premisecitation
The SASP-associated cytokines TNF, IFN, and IL-6 all play significant roles in the pathogenesis of myeloproliferative neoplasms (MPNs), MDSs, and acute myeloid leukemia (AML).
“In particular, the SASP-associated cytokines TNF, IFN, and IL-6 all play significant roles in the pathogenesis of myeloproliferative neoplasms (MPNs), 52 MDSs, 53 and acute myeloid leukemia (AML).54”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [52] Reynaud, 2011, IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development, Cancer Cell source
Not checked in the free run.
- cites [53] Gañán-Gómez, 2015, Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes, Leukemia source
Not checked in the free run.
- cites [54] Rambaldi, 1991, Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells, Blood source
Not checked in the free run.
- Premisecitation
Pharmacological inhibition of IL-1 signaling resulted in recovery of the aged hematopoietic system from inflammatory (regenerative) stress.
“The pharmacological inhibition of IL-1 signaling resulted in recovery of the aged hematopoietic system from inflammatory (regenerative) stress.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Verovskaya, 2018, Inflammatory changes in the bone marrow microenvironment drive both niche and blood system remodeling during aging, Exp Hematol source
Not checked in the free run.
- Interpretationnone given
The prototypical example of a hematological disease caused by BM inflammation is aplastic anemia (AA).
“The prototypical example of a hematological disease caused by BM inflammation is aplastic anemia (AA).”
Quote in the paperNot a substantial claim - Interpretationreasoning
The aberrant inflammatory microenvironment makes necessary contributions to drive the induction, selection, and eventual expansion of mutant clones that are poised for subsequent malignant transformation.
“Together, the data point to necessary contributions of the aberrant (inflammatory) microenvironment to drive the induction, selection, and eventual expansion of mutant clones that are poised for subsequent malignant transformation.”
- Also stated in: § Inflammatory BM microenvironment and myeloid malignancies · boosted
“However, the data summarized herein point to necessary contributions of the aberrant (inflammatory) microenvironment to drive the induction, selection, and eventual expansion of mutant clones that are poised for subsequent malignant transformation.”
Quote in the paperSubstantial claim - Also stated in: § Inflammatory BM microenvironment and myeloid malignancies · boosted
- Interpretationown data
Inflammation in distinct (spatial) niches of the BM has distinct effects on hematopoiesis.
“These studies demonstrate that inflammation in distinct (spatial) niches of the BM have distinct effects on hematopoiesis.”
Quote in the paperSubstantial claim - Premisenone given
MDSCs can contribute to prevalent inflammation by secreting proinflammatory factors like S100A8/A9.
“On the other hand, MDSCs can contribute to the prevalent inflammation by secreting proinflammatory factors like S100A8/A9.”
Quote in the paperNot a substantial claim - Interpretationnone given
These alarmins exert specific effects on HSPCs depending on different niches of the BM.
“These alarmins exert specific effects on HSPCs depending on different niches of the BM.”
Quote in the paperNot a substantial claim - Premisecitation
Secreted S100 proteins cause autocrine activation and expansion of MDSCs via binding of CD33/Siglec-3.
“Secreted S100 proteins cause autocrine activation and expansion of MDSCs via binding of CD33/Siglec-3.75”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Sallman, 2019, The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes, Blood source
Not checked in the free run.
- Premisecitation
In the majority of AA patients, glycosylphosphatidylinositol-specific T cells can be detected.
“In the majority of AA patients, glycosylphosphatidylinositol-specific T cells can be detected.61,62”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [61] Gargiulo, 2007, Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria, Blood source
Not checked in the free run.
- cites [62] Giudice, 2018, Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia, Haematologica source
Not checked in the free run.
- Premisecitation
TET2-deficient macrophages are hyperinflammatory.
“TET2-deficient macrophages are hyperinflammatory”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Zhang, 2015, Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6, Nature source
Not checked in the free run.
- Premisenone given
Inflammation driving expansion of resistant clones is beginning to be documented in the case of TET2 mutations.
“Furthermore, inflammation driving expansion of resistant clones is beginning to be documented in the case of TET2 mutations.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The coincidence of PNH with AA provides an escape mechanism wherein the PNH clone can restore hematopoiesis by evading immune-mediated eradication.
“Thus, the coincidence of PNH with AA provides an escape mechanism wherein the PNH clone can restore hematopoiesis by evading immunemediated eradication.”
Quote in the paperSubstantial claim - Interpretationreasoning
Malignant hematopoietic cells diminish the hematopoietic-supportive capacity of BM stromal and niche cells indirectly through changes in the physical and cytokine environment.
“These data indicate that malignant hematopoietic cells diminish the hematopoietic-supportive capacity of BM stromal and niche cells indirectly through changes in the physical and cytokine environment.”
Quote in the paperSubstantial claim - Premisecitation
Under perpetuated inflammatory conditions, early granulocytic or monocytic precursors (not derived from the dysplastic clone) differentiate into granulocytic or polymorphonuclear MDSCs and monocytic MDSCs.
“Under perpetuated inflammatory conditions, early granulocytic or monocytic precursors (not derived from the dysplastic clone) differentiate into granulocytic or polymorphonuclear MDSCs and monocytic MDSCs, respectively.[72][73][74]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72][73][74]
Not checked in the free run.
- Premisecitation
There is a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.
“These findings are supported by recent findings demonstrating a causal link between mutations in HSPCs in the context of clonal hematopoiesis with indeterminate origin and altered transcriptional output of macrophages, which affect the vascular wall and contributes to atherosclerosis.83,84”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Other mutations commonly found in clonal hematopoiesis can be selected due to overall BM hypocellularity.
“Other mutations commonly found in clonal hematopoiesis can simply be selected due to the overall BM hypocellularity.64”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] Risitano, 2017, Immune insights into AA, Blood source
Not checked in the free run.
- Premisecitation
Allogeneic stem cell transplantation with a reduced-intensity conditioning regimen, thought to preserve the host stroma, is a successful therapy for reinstating hematopoiesis in eligible patients.
“Moreover, allogenic stem cell transplantation with a reduced-intensity conditioning regimen, which is thought to preserve the host stroma, is a successful therapy for reinstating hematopoiesis in eligible patients.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Spyridonidis, 2005, Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin, Stem Cells Dev source
Not checked in the free run.
- Premisecitation
Tet2 knockout murine and TET2-mutant human HSPCs have a clonal advantage caused by resistance to apoptosis in an in vitro environment that contains the proinflammatory cytokine TNFa.
“Tet2knockout murine and TET2-mutant human HSPCs have a clonal advantage caused by resistance to apoptosis in an in vitro environment that contains the proinflammatory cytokine TNFa.85”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Zhang, 2015, Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6, Nature source
Not checked in the free run.
- Premisecitation
Macrophages regulate HSPCs indirectly through interaction with MSCs.
“Previous studies demonstrated that macrophages regulate HSPCs indirectly through interaction with MSCs.82”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Winkler, 2010, Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs, Blood source
Not checked in the free run.
- Premisenone given
Hyperactive innate immune signaling (eg, via MyD88/IRAK and TRAF6) has emerged as a key driver in myeloid malignancies and leukemic progression.
“It has become evident over the last several years that hyperactive innate immune signaling (eg, via the myeloid differentiation primary response 88/IL-1 receptor-associated kinase pathway and TNF receptor-associated factor 6, representing downstream signaling of innate immune inputs including TLRs) has emerged as a key driver in myeloid malignancies and also leukemic progression.”
Quote in the paperSubstantial claim - Premisecitation
OBCs expand in the presence of malignant hematopoietic cells resulting in extensive remodeling of the BM microenvironment.
“Schepers et al demonstrated that OBCs expand in the presence of malignant hematopoietic cells resulting in extensive remodeling of the BM microenvironment.8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Schepers, 2013, Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche, Cell Stem Cell source
Not checked in the free run.
- Premisecitation
The aging BM microenvironment is composed of increasing amounts of damage-associated molecular patterns.
“Furthermore, the aging BM microenvironment is composed of increasing amounts of damageassociated molecular patterns.69”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Huang, 2015, DAMPs, ageing, and cancer: the ‘DAMP hypothesis’, Ageing Res Rev source
Not checked in the free run.
- Premisecitation
Molecular alterations in niche cells by themselves have been shown to induce myeloid malignancies.
“Molecular alterations in niche cells by themselves have been shown to induce myeloid malignancies.78”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Raaijmakers, 2010, Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia, Nature source
Not checked in the free run.
- Premisecitation
Aberrant production of inflammatory signals in niche cells such as IFN, IL-1, and alarmins S100A8 and S100A9 significantly contributes to myeloid disease.
“The aberrant production of inflammatory signals in niche cells such as IFN, IL-1, and particularly in alarmins S100A8 and S100A9 (damage associated molecular pattern that signals via TLR4) was also shown to significantly contribute to myeloid disease.8,52,[66][67][68]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 8,52,[66][67][68]
Not checked in the free run.
- Interpretationreasoning
Hypocellular MDS can be understood as an exhausted form of AA in which selective clones have been established.
“Thus, hypocellular MDS can be understood as an exhausted form of AA in which selective clones have been established.65”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Barrett, 2000, Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?, Semin Hematol source
Not checked in the free run.
- Interpretationreasoning
Myeloid malignancies need to be considered as a systemic disease including both hematopoietic cells and their different microenvironment characterized by distinct functions.
“The data strongly argue that myeloid malignancies needs to be considered as a systemic disease including both hematopoietic cells and their different microenvironment characterized by distinct functions.”
Quote in the paperSubstantial claim - Interpretationreasoning
Increased ROS induce genotoxic stress for HSCs.
“inducing genotoxic stress for HSCs”
Quote in the paperSubstantial claim - Interpretationnone given
Chronic inflammation leads to loss of support of normal hematopoiesis.
“Chronic inflammation leads to loss of support of normal hematopoiesis”
Quote in the paperSubstantial claim - Interpretationnone given
Inflammation promotes normal HSC development and function in acute stress situations.
“promoting normal HSC development and function in acute stress situations”
Quote in the paperNot a substantial claim - Premisecitation
Anti-inflammatory strategies are finding their way into clinical practice.
“However, anti-inflammatory strategies are finding their way into clinical practice.53,[66][67][68]75”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 53,[66][67][68]75
Not checked in the free run.
- Interpretationreasoning
Cross talk between HSPCs and their microenvironment contributes to disease initiation and evolution.
“Cross talk between HSPCs and their microenvironment contributes to disease initiation and evolution.”
Quote in the paperSubstantial claim - Interpretationreasoning
This leads to significant alterations in HSC function and output.
“This leads to significant alterations in HSC function and output.”
Quote in the paperSubstantial claim - Premisecitation
For AA, which is predominantly mediated by T effector cells and their secreted cytokines, immunosuppressive therapy with ciclosporin and antithymocyte globulin to deplete the T-cell response is an established strategy with good success rates.
“For AA, which is predominantly mediated by T effector cells and their secreted cytokines, immunosuppressive therapy with ciclosporin and antithymocyte globulin to deplete the T-cell response is an established strategy with good success rates.89”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Killick, 2016, Guidelines for the diagnosis and management of adult aplastic anaemia, Br J Haematol source
Not checked in the free run.
- Interpretationreasoning
Erythroid differentiation is significantly impaired leading to anemia of chronic inflammation or anemia in the elderly.
“The erythroid differentiation is significantly impaired leading to anemia (anemia of chronic inflammation or anemia in the elderly).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Continuous exposure to inflammatory stress leads to increased reactive oxygen levels (ROS) in the BM microenvironment.
“and increased reactive oxygen levels (ROS)”
Quote in the paperSubstantial claim - Premisecitation
AML can lead to the induction of MDSCs and Tregs, which dampen adaptive immune response in close proximity to leukemic cells.
“AML can lead to the induction of MDSCs and Tregs, which dampen adaptive immune response in close proximity to leukemic cells.32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Lamble, 2018, Targeting the immune microenvironment in acute myeloid leukemia: a focus on T cell immunity, Front Oncol source
Not checked in the free run.
- Interpretationreasoning
Normal hematopoiesis may be impaired such that preexisting HSC clones carrying potentially leukemic mutations have increased potential to expand and evolve.
“Normal hematopoiesis may thus also be impaired in a manner such that preexisting HSC clones carrying potentially leukemic mutations have increased potential to expand and evolve.”
Quote in the paperSubstantial claim - Interpretationreasoning
Sustained inflammation promotes HSC deregulation and functional decline and even malignancy.
“while promoting HSC deregulation and functional decline and even malignancy if sustained”
Quote in the paperSubstantial claim - Interpretationreasoning
Malignant cells have a higher capacity to resist inflammatory and immunological responses compared with physiological hematopoietic cells.
“However, it is important to note that malignant cells have a higher capacity to resist inflammatory and immunological responses compared with physiological hematopoietic cells.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Genotoxic stress potentially promotes genomic instability in HSCs.
“potentially promoting genomic instability”
Quote in the paperSubstantial claim - Interpretationreasoning
Chronic inflammation in the BM microenvironment may function as an initiator or even driver of hematological malignancies.
“Thus, chronic inflammation in the BM microenvironment may function as an initiator or even driver of hematological malignancies.”
Quote in the paperSubstantial claim - Interpretationreasoning
Continuous exposure to inflammatory stress leads to dysfunction of the BM microenvironment.
“The continuous exposure to this stress situation leads to dysfunction of the BM microenvironment”
Quote in the paperSubstantial claim
- May combine two claims. 56
- Classified as probably not a substantial claim. 14
May combine two claims.
Findingown dataS100A8 is responsible for the erythroid-differentiation defect: addition of recombinant S100A8 was sufficient to induce a differentiation defect in wild-type erythroid cells, and genetic inactivation of S100A8 expression rescued the erythroid-differentiation defect of Rps14-haploinsufficient HSCs.
“We demonstrated specifically that S100A8 is responsible for the erythroid-differentiation defect as addition of recombinant S100A8 was sufficient to induce a differentiation defect in wild-type erythroid cells, and genetic inactivation of S100A8 expression rescued the erythroid-differentiation defect of Rps14-haploinsufficient HSCs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ribezzo, 2019, Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome, Leukemia source
Not checked in the free run.
May combine two claims.
Findingown dataStromal (Gli1+) MSCs in MPN show altered expression of many HSC-regulatory genes and cytokines, including broad downregulation of HSC-retention factors, particularly CXCL12, in myelofibrosis, indicating transcriptional reprogramming from hematopoiesis support to inflammatory (profibrotic) programs.
“Also, our own data on the role of stromal (Gli11) MSCs in MPN showed altered expression of many HSC-regulatory genes and cytokines, including a broad downregulation of HSC-retention factors, in particular CXCL12, in myelofibrosis, indicating transcriptional reprogramming from hematopoiesis support to inflammatory (profibrotic) programs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationErythroblastic islands are specialized niches supporting the proliferation and differentiation of erythroblasts, characterized by a central macrophage extending cytoplasmic protrusions to a ring of adjacent erythroblasts, and the interaction of cells within the island is crucial for early and late stages of erythroid maturation.
“Erythroblastic islands are very specialized niches supporting the proliferation and differentiation of erythroblasts.14 Erythroid islands are characterized by a central macrophage that extends cytoplasmic protrusions to a ring of adjacent erythroblasts.The interaction of cells within the island is crucial for early and late stages of erythroid maturation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Chasis, 2008, Erythroblastic islands: niches for erythropoiesis, Blood source
Not checked in the free run.
May combine two claims.
PremisecitationPerivascular mesenchymal cells that express CD146 in humans and Cxcl12-GFP, Nestin-GFP, full-length Leptin receptor, Prx-1-Cre, Osterix-Cre, and inducible Mx-1-Cre in mice generate osteoblastic cells and express factors that promote the maintenance of HSPCs.
“Although MSCs are a heterogeneous population and still require better characterization by surface markers, perivascular mesenchymal cells that express CD146 in humans and Cxcl12-green fluorescent protein, Nestin-green fluorescent protein, full-length Leptin receptor, Prx-1-Cre, Osterix-Cre, and inducible Mx-1-Cre in mice generate osteoblastic cells and express factors that promote the maintenance”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Morrison, 2014, The bone marrow niche for haematopoietic stem cells, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOther cell types that regulate HSC niches include osteoclasts, extracellular matrix, megakaryocytes, and calcium.
“Other cell types that regulate HSC niches include osteoclasts, extracellular matrix, megakaryocytes, and calcium.9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Morrison, 2014, The bone marrow niche for haematopoietic stem cells, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationCXCL12 is essential in homing HSCs to the BM whereas KITL (SCF-1) supplies hematopoietic progenitors with an essential survival signal.
“CXCL12 is essential in homing HSCs to the BM whereas KITL (also known as stem cell factor 1 [SCF-1]) supplies hematopoietic progenitors with an essential survival signal.[10][11][12]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10][11][12]
Not checked in the free run.
May combine two claims.
PremisecitationSeveral stromal cell populations are involved in the regulation of hematopoiesis, and specific stromal cell populations regulate distinct hematopoietic progenitor populations.
“Several stromal cell populations are involved in the regulation of hematopoiesis, and recent studies have dissected and defined the role of specific stromal cell populations on regulating distinct hematopoietic progenitor populations.[3][4][5]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3][4][5]
Not checked in the free run.
May combine two claims.
PremisereasoningUnder normal conditions, HSCs are in a quiescent state; in response to inflammation, they rapidly start losing quiescence and transiently proliferate, also due to disturbed signals from their niche.
“Under normal conditions, HSCs are in a quiescent state.In response to inflammation, they rapidly start losing quiescence and transiently proliferate, also due to disturbed signals from their niche.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationAging-associated intrinsic HSC alterations, including reduced self-renewal and myelopoiesis-skewed differentiation, strongly resemble functional changes of HSCs exposed to chronic inflammation, with increase of CD150 high HSCs giving rise to predominantly myeloid lineage cells.
“Aging-associated (intrinsic) HSC alterations, including reduced self-renewal and myelopoiesis-skewed differentiation, strongly resemble the functional changes of HSCs exposed to chronic inflammation: increase of CD150 high HSCs giving rise to predominantly myeloid lineage cells (myeloid skewing).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTNF-a induces activation of caspases in erythroid precursor cells; subsequent cleavage and depletion of GATA-1 boosts PU.1-mediated skewing.
“In concert, another prominent inflammatory cytokine, TNF-a, induces activation of caspases in erythroid precursor cells.The subsequent cleavage and depletion of GATA-1 as vital transcription factor for the erythroid lineage boosts the PU.1-mediated skewing.29,30”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29] Back, 2004, PU.1 determines the self-renewal capacity of erythroid progenitor cells, Blood source
Not checked in the free run.
- cites [30] Felli, 2005, Multiple members of the TNF superfamily contribute to IFN-γ-mediated inhibition of erythropoiesis, J Immunol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAging not only causes intrinsic changes in HSCs but also induces significant changes in the BM microenvironment, leading to extrinsic mechanisms in HSC regulation.
“Thus, aging not only causes intrinsic changes in HSCs, but also induces significant changes in the BM microenvironment (leading to extrinsic mechanisms in HSC regulation).”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenInflammation in the natural aging process is reflected by anemia, immunosenescence, and thrombocytosis.
“Inflammation in the natural aging process is reflected by anemia, immunosenescence, and thrombocytosis.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIt is very likely that MSCs in both the endosteal and perivascular niche acquire inflammatory programs and directly affect the maturation of neighboring HSPCs.
“Thus, it is very likely that MSCs in both the endosteal and perivascular niche also acquire inflammatory programs and directly affect the maturation of neighboring HSPCs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningInflammatory signals induce lineage specification by different mechanisms in HSCs and impair HSC self-renewal.
“Furthermore, inflammatory signals induce lineage specification by different mechanisms in HSCs and impairs HSC self-renewal.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningMSCs and endothelial cells express various cytokine/chemokine receptors and PRRs and sense an inflammatory milieu due to hematopoietic challenges.
“Although spatial effects of inflammation in MSCs from different niches (endosteal and perivascular) have not been dissected specifically as compared with the interplay between the central macrophage and erythroid progenitor cells in the erythroid island, it has become increasingly clear that MSCs and endothelial cells (ECs) express various cytokine/chemokine receptors and PRRs.They sense an”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningInflammation affects the cellular functions of MSCs and ECs and influences hematopoiesis mainly through cytokine secretion or reaction to cytokines.
“These studies suggest that inflammation affects the cellular functions of MSCs and ECs, and influences hematopoiesis mainly through cytokine secretion or reaction to cytokines.[39][40][41]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39][40][41]
Not checked in the free run.
May combine two claims.
PremisecitationThrough differentiation into mature adipocytes, multipotent MSCs lose their capacity to produce hematopoiesis-supporting factors such as CXCL-12, IGF-1, and Kitl, and the concentration of these is inversely correlated with the amount of BM fat.
“Through differentiation into mature adipocytes, multipotent MSCs lose their capacity to produce hematopoiesis supporting factors such as CXCL-12, IGF-1, and Kitl.The concentration of these is inversely correlated with the amount of BM fat.50”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Tuljapurkar, 2011, Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging, J Anat source
Not checked in the free run.
May combine two claims.
PremisecitationIn response to TLR4 activation, G-CSF is predominantly produced in ECs and strongly stimulates emergency granulopoiesis with recruitment of neutrophils to the site of infection.
“In response to TLR4 activation, G-CSF is predominantly produced in ECs, and strongly stimulates emergency granulopoiesis with recruitment of neutrophils to the site of infection.38”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Manz, 2014, Emergency granulopoiesis, Nat Rev Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationMyeloid cells and adipocytes produce numerous proinflammatory cytokines leading to a vicious cycle with accumulation of myeloid or myeloid-skewed cells in the BM.
“Myeloid cells and adipocytes further produce numerous proinflammatory cytokines leading to a vicious cycle with accumulation of myeloid or myelodid-skewed cells in the BM.48”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48] Biasco, 2016, In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases, Cell Stem Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIFN-g can directly affect HSCs: STAT1 signaling leads to cycling and differentiation, ultimately resulting in stem cell exhaustion, whereas upregulation of SOCS1 blocks self-renewing capacities.
“IFN-g can directly affect HSCs: STAT1 signaling leads to cycling and differentiation, ultimately resulting in stem cell exhaustion, whereas upregulation of SOCS1 blocks the self-renewing capacities.56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Chen, 2015, IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure, Blood source
Not checked in the free run.
May combine two claims.
PremisecitationAdipocytes secrete mediators suppressing hematopoiesis and upholding a proinflammatory environment such as TNF-a.
“Moreover, adipocytes have been described to secrete mediators suppressing hematopoiesis and upholding a proinflammatory environment such as TNF-a.51”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Naveiras, 2009, Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment, Nature source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe inflammatory microenvironment in the old BM cavity drives remodeling of the niche and hematopoiesis, and blocking proinflammatory cytokines is instrumental in reverting aging of the BM niche and impaired regenerative potential of old HSCs.
“This study proposed that the inflammatory microenvironment in the old BM cavity drives remodeling of the niche and hematopoiesis.They proposed that blocking of proinflammatory cytokines is instrumental in reverting the aging of the BM niche and the impaired regenerative potential of old HSCs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Verovskaya, 2018, Inflammatory changes in the bone marrow microenvironment drive both niche and blood system remodeling during aging, Exp Hematol source
Not checked in the free run.
May combine two claims.
InterpretationcitationQuiescence prevents HSC depletion during chronic inflammation, indicating that multipotent progenitor (MPP) cells compensate the ongoing need, minimizing the necessity for HSCs to proliferate.
“Quiescence prevents HSC depletion during chronic inflammation.This indicates that multipotent progenitor (MPP) cells, responsible for daily blood maintenance, compensate the ongoing need, thereby minimizing the necessity for HSCs to proliferate.25”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Pietras, 2017, Inflammation: a key regulator of hematopoietic stem cell fate in health and disease, Blood source
Not checked in the free run.
May combine two claims.
PremisecitationInflammation, particularly with IL-6 as a central mediator, affects iron metabolism, thereby affecting hemoglobin synthesis and causing anemia.
“Inflammation, in particular with IL-6 as a central mediator, affects iron metabolism, thereby affecting hemoglobin synthesis and, hence, anemia.27”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Macciò, 2005, Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia, Blood source
Not checked in the free run.
May combine two claims.
PremisecitationUpregulation of TNF family member proteins in nursing macrophages and maturing erythroblasts inhibits their differentiation and induces extrinsic apoptosis.
“Additionally, upregulation of TNF family member proteins in nursing macrophages as well as maturing erythroblasts inhibits their differentiation even further and induces extrinsic apoptosis.31”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Koury, 2015, Anaemia in kidney disease: harnessing hypoxia responses for therapy, Nat Rev Nephrol source
Not checked in the free run.
May combine two claims.
Premisenone givenRecent evidence suggests that altered transcriptional landscapes, abnormal transduction of signaling cascades, epigenetic modifications, cytoskeletal polarity, cellular senescence, and clonal selection are key features of the aging process.
“Recent evidence suggests that altered transcriptional landscapes, abnormal transduction of signaling cascades, epigenetic modifications, cytoskeletal polarity, cellular senescence, and clonal selection are key features of the aging process.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRecent single-cell studies on niche cells in young and aged mice demonstrated activation of inflammatory response programs, changes in osteoblastic differentiation, and metabolism with age, particularly through upregulation of IL1a/b.
“Recent single-cell studies on niche cells in young and aged mice demonstrated activation of inflammatory response programs, changes in osteoblastic differentiation, and also metabolism with age, in particular through upregulation of IL1a/b.47”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Verovskaya, 2018, Inflammatory changes in the bone marrow microenvironment drive both niche and blood system remodeling during aging, Exp Hematol source
Not checked in the free run.
May combine two claims.
PremisecitationUnder inflammatory conditions, the central macrophage can become a source of inflammatory mediators; IFN-g secreted by the central macrophage downregulates the Epo receptor on erythroid precursors while upregulating PU.1.
“Interestingly, under inflammatory conditions, the central macrophage itself can become a source of inflammatory mediators.IFN-g, secreted by the central macrophage, downregulates the Epo receptor on erythroid precursors, while at the same time upregulating PU.1.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationG-CSF, upregulated in infection, can enhance myelopoiesis through MSCs and suppress the production of CXCL12 from MSCs in the BM.
“Granulocyte colony-stimulating factor (G-CSF), as a myeloid-supporting cytokine that is upregulated in infection, can enhance myelopoiesis through MSCs and suppress the production of CXCL12 from MSCs in the BM.34”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Keating, 2012, Mesenchymal stromal cells: new directions, Cell Stem Cell source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBoth senescence/aging and other dysfunctions of the BM niche caused by chronic disease, infection, or aging may lead to overproduction of inflammatory signals that affect HSPCs and alter the fitness of their regulation microenvironment, which might lead to a microenvironment supporting transformed clones and not normal hematopoiesis, leading to a vicious cycle that further promotes expansion of a
“In summary, both senescence/ aging and other dysfunctions of the BM niche caused by chronic disease, infection, or aging may lead to overproduction of inflammatory signals that affect HSPCs and alter the fitness of their regulation microenvironment, which might lead to a microenvironment supporting transformed clones and not normal hematopoiesis, leading to a vicious cycle that further promotes”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA type 1 T-helper (Th1) cell-skewed response of the adaptive immune system is a major effector of damage and the major source of IFN-g, accompanied by a reduction in regulatory T cells (Tregs) in the marrow.
“Another major effector of damage is a type 1 T-helper (Th1) cell-skewed response of the adaptive immune system, which was also identified as the major source of IFN-g, accompanied by a reduction in regulatory T cells (Tregs) in the marrow.60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Solomou, 2007, Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia, Blood source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIntrinsic defects of MDS hematopoietic cells directly alter the surrounding microenvironment, which in turn negatively affects hematopoiesis as an extrinsic mechanism.
“These data indicate that intrinsic defects of MDS hematopoietic cells directly alter the surrounding microenvironment, which in turn negatively affects hematopoiesis as an extrinsic mechanism.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenMalignant cells use elaborate ways to shield themselves from immune response.
“Importantly, malignant cells use elaborate ways to shield themselves from immune response.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenIncreased S100A8/S100A9 levels in the BM are linked to anemia and an increase in monocytes.
“Increased S100A8/S100A9 levels in the BM are linked to anemia and an increase in monocytes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA CD1-restricted T-cell response can lead to elimination of hematopoietic cells while creating a selective advantage for clones with deficiency for phosphatidylinositol glycan biosynthesis class A protein, reported in patients with paroxysmal nocturnal hemoglobinuria (PNH).
“A CD1-restricted T-cell response can lead to an elimination of hematopoietic cells, while at the same time creating a selective advantage for clones with deficiency for phosphatidylinositol glycan biosynthesis class A protein, reported in patients with paroxysmal nocturnal hemoglobinuria (PNH).63”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Gargiulo, 2013, Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria, Blood source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased IL-6 production or activation of TLR2 is critical for the development of the myeloproliferative phenotype of TET2-deficient hematopoietic cells.
“increased IL-6 production or activation of TLR2 is critical for the development of the myeloproliferative phenotype of TET2-deficient hematopoietic cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Zhang, 2015, Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone given§ INFLAMMATION AND HEMATOPOIESIS: THE IMPACT OF INFLAMMATION ON THE BONE MARROW MICROENVIRONMENT | Inflammatory bone marrow microenvironmentA 'reprogrammed' inflammatory microenvironment is a common theme in myeloid malignancies.
“A”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe microenvironment is massively 'reprogrammed' in myeloid malignancies and is inflammatory, leading to loss of function of the microenvironment.
“Thus, the conclusion can only be that the microenvironment is massively”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn murine models of MPN and AML, the hematological malignancy created neuropathic changes in the BM niche, which affected the activity of MSCs and altered the function of the HSC niche, leading to downregulated expression of many HSC-retention factors, including CXCL12 and SCF.
“In murine models of MPN 80 and AML, 81 the hematological malignancy created neuropathic changes in the BM niche, which affected the activity of MSCs and altered the function of the HSC niche, in particular leading to downregulated expression of many HSC-retention factors, including CXCL12 and SCF, indicating loss of hematopoiesis support.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [80] Arranz, 2014, Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms, Nature source
Not checked in the free run.
- cites [81] Hanoun, 2014, Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche, Cell Stem Cell source
Not checked in the free run.
May combine two claims.
InterpretationcitationMacrophages and monocytes are increased in chronic inflammatory states in aging and in myeloid malignancies and might be an important contributor to remodeling of the BM microenvironment in inflammation and hematopoietic disease.
“Macrophages and monocytes, as cells of the innate immune response, are increased in chronic inflammatory states in aging and in myeloid malignancies and might be an important contributor to the remodeling of the BM microenvironment in inflammation and hematopoietic disease (anemia, BM failure, and also leukemia).70”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Ribezzo, 2019, Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome, Leukemia source
Not checked in the free run.
May combine two claims.
PremisecitationAccumulation of inflammatory myelofibrotic cells and downregulation of factors regulating niche function and HSC retention, including CXCL12, n-cadherin, SCF, angiopoietin-1, and TGF-1 and -2, occur in this context.
“They demonstrated the accumulation of inflammatory myelofibrotic cells in this context and downregulation of factors regulating the niche function and HSC retention, including the chemokine CXCL12, n-cadherin, SCF, angiopoietin-1, and TGF-1 and -2.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Schepers, 2013, Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche, Cell Stem Cell source
Not checked in the free run.
May combine two claims.
Premisenone givenHSC attrition or leukemic transformation has been observed when inflammation is accompanied by cell-intrinsic DNA repair defects in HSCs or further fueled by dysregulated mechanisms in the BM microenvironment, particularly inflammation in niche cells.
“One hint might be that HSC attrition or leukemic transformation has been observed when inflammation is accompanied by cell-intrinsic DNA repair defects in HSCs or further fueled by dysregulated mechanisms in the BM microenvironment, in particular inflammation, particularly in niche cells.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRaaijmakers and colleagues confirmed these results and additionally showed increased levels of S100A8 in the mesenchymal niche in MDS and Shwachman-Bodian-Diamond syndrome, which affects HSCs through excessive ROS production and genotoxic stress.
“Raaijmakers and colleagues confirmed these results and additionally showed increased levels of S100A8 in the mesenchymal niche in MDS and Shwachman-Bodian-Diamond syndrome, which affects HSCs through excessive reactive oxygen species (ROS) production and genotoxic stress.68,71”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [68] Zambetti, 2016, Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia, Cell Stem Cell source
Not checked in the free run.
- cites [71] Chen, 2016, Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs, Leukemia source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe BM microenvironment is abnormal in myeloid malignancies and exhibits great similarities to an inflammatory state.
“In summary, we know that the BM microenvironment is abnormal in myeloid malignancies, and exhibits great similarities to an inflammatory state.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMDSCs are sufficient to create an MDS phenotype in murine experiments, and targeting them or their expansion leads to reconstitution of normal hematopoiesis.
“MDSCs are sufficient to create an MDS phenotype in murine experiments, and targeting them or their expansion leads to reconstitution of normal hematopoiesis.76,77”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [76] Chen, 2013, Induction of myelodysplasia by myeloid-derived suppressor cells, J Clin Invest source
Not checked in the free run.
- cites [77] Eksioglu, 2017, Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858, Leukemia source
Not checked in the free run.
May combine two claims.
Interpretationnone givenAdipocytes are increased in the aged BM and can release inflammatory signals.
“Adipocytes are increased in the aged BM and can also release inflammatory signals.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenDisease-related chronic inflammation and/or physiological aging leads to continuous production of proinflammatory signals systemically and locally in the BM.
“Disease-related chronic inflammation and/or physiological aging leads to the presence of continuous production of proinflammatory signals (systemically and locally in the BM).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningFor other diseases defined by a less specific inflammatory BM microenvironment, intervention does not seem to be as straightforward.
“For other diseases, defined by a less specific inflammatory BM microenvironment, intervention does not seem to be as straightforward.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe central macrophage of the erythroblastic island can acquire an inflammatory phenotype and further contributes to inflammation in the BM microenvironment.
“The central macrophage of the erythroblastic island can also acquire an inflammatory phenotype and further contributes to inflammation in the BM microenvironment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe mechanisms of immune evasion are as heterogeneous as AML itself and dependent on the differentiation stage of AML blasts.
“The mechanisms of immune evasion are as heterogeneous as AML itself and dependent on the differentiation stage of AML blasts.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenClonal hematopoiesis is observed with increasing frequency with age, but not all aging individuals develop hematologic malignancies or BM failure.
“although clonal hematopoiesis is observed with increasing frequency with age, not all aging individuals develop hematologic malignancies or BM failure.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThis leads to an inflammatory BM microenvironment as MSCs acquire an inflammatory secretory phenotype and release proinflammatory signals affecting the HSC niche and erythroblastic islands.
“In turn, this leads to an inflammatory BM microenvironment as MSCs of the BM, for example, nestin 1 (Nes 1 ), Gli1 1 , leptin-receptor (LepR 1 ) cells, acquire an inflammatory, secretory phenotype as well and also release proinflammatory signals that affect both the HSC niche and also the erythroblastic islands.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMyeloid cells expand and innate immune cells/MDSCs are recruited.
“Myeloid cells expand and innate immune cells/MDSCs are recruited.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenHigh numbers of platelets are released by megakaryocytes whereas lymphoid cells decrease.
“High numbers of platelets are released by megakaryocytes whereas lymphoid cells decrease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe reasons for not all aging individuals developing hematologic malignancies or BM failure are not clear, but likely involve interactions between cell-intrinsic and microenvironmental mechanisms as well as genetic/epigenetic factors.
“The reasons for this are not clear, but likely involve interactions between cell-intrinsic and microenvironmental mechanisms as well as the genetic/epigenetic”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningChronic inflammation can lead to decreased self-renewal of HSCs and skewed lineage output.
“and can lead to decreased self-renewal of HSCs and skewed lineage output.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenInflammation in the BM microenvironment seems to be a common stress response to various stimuli.
“In summary, inflammation in the BM microenvironment seems to be a common stress response to various stimuli.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThere is a wide overlap between immune evasion strategies in AML and those observed in solid tumors.
“There is a wide overlap with evasion strategies observed in solid tumors.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBlasts and malignant driver cells in MPNs upregulate B7-family proteins or programmed death-ligand 1 (PD-L1), inhibiting T cells through interaction with CTLA-4 and PD-1, respectively.
“Blasts and malignant driver cells in MPNs have also been described to upregulate B7-family proteins or programmed death-ligand 1 (PD-L1), inhibiting T cells through interaction with CTLA-4 and PD-1, respectively.[86][87][88]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86][87][88]
Not checked in the free run.
May combine two claims.
Interpretationnone givenThe erythroid system is very sensitive to inflammation and is affected in a majority of MDS cases.
“as the erythroid system in particular is very sensitive to inflammation and is in a majority of cases affected in MDSs.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenInflammatory signaling in the microenvironment is deeply intertwined with the function of HSPCs and affects fate decisions.
“It becomes increasingly clear that inflammatory signaling in the microenvironment is deeply intertwined with the function of HSPCs and affecting fate decisions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenAging-induced inflammation can be considered a physiological process, and it is not clear whether anti-inflammatory treatment without signs of malignancy or dysplasia in the BM would be beneficial.
“Although affecting hematopoiesis, aging-induced inflammation can be considered a physiological process and it is not clear whether anti-inflammatory treatment without any signs of malignancy of dysplasia in the BM were beneficial.”
Quote in the paperNot a substantial claim
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Elevated cortisol and catecholamines act on bone marrow, leading to an expansion of myeloid lineages at the expense of lymphoid progenitors, creating a microenvironment that favors autoimmunity.
“Elevated cortisol and catecholamines act on bone marrow, leading to an expansion of myeloid lineages at the expense of lymphoid progenitors, thereby creating a microenvironment that favors autoimmunity [79].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [79]
In the inflammation-induced hematopoiesis section (page not provided), the paper reports that inflammatory signals can induce myeloid differentiation. Its effector-molecule table also lists G-CSF as stimulating myelopoiesis and inhibiting lymphopoiesis. The cited copy does not link this shift to elevated cortisol or catecholamines, or say that it creates a microenvironment favoring autoimmunity. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Cites
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · see citing works
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · see citing works
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713 · see citing works
Stöckl, S., Göttl, C., Grifka, J. K., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,670 · see citing works
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683 · see citing works
The bone marrow niche for haematopoietic stem cells
Morrison, S. J., & Scadden, D. T. (2014) · Nature · doi:10.1038/nature12984 · Cited by 2,451 · see citing works
Sugiyama, T., Kohara, H., Noda, M., & Nagasawa, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.016 · Cited by 2,419 · see citing works
Myeloid-derived suppressor cells coming of age
Veglia, F., Perego, M., & Gabrilovich, D. I. (2018) · Nature Immunology · doi:10.1038/s41590-017-0022-x · Cited by 1,766 · see citing works
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,617 · see citing works
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452 · see citing works
IFNα activates dormant haematopoietic stem cells in vivo
Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A. (2009) · Nature · doi:10.1038/nature07815 · Cited by 1,368 · see citing works
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment
Naveiras, O., Nardi, V., Wenzel, P. L., Hauschka, P. V., Fahey, F., & Daley, G. Q. (2009) · Nature · doi:10.1038/nature08099 · Cited by 1,129 · cited 3× · see citing works
“Moreover, adipocytes have been described to secrete mediators suppressing hematopoiesis and upholding a proinflammatory environment such as TNF-a.(51) As the inflammatory pathways activated in aging also play a role in the pathogenesis of hematological disease, significant interest has emerged in studying the interact…”
BackgroundBone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Raaijmakers, M. H. G. P., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., et al. (2010) · Nature · doi:10.1038/nature08851 · Cited by 1,115 · see citing works
Adipose-derived stem cells: Isolation, expansion and differentiation☆
Bunnell, B. A., Flaat, M., Gagliardi, C., PATEL, B., & RIPOLL, C. (2008) · Methods · doi:10.1016/j.ymeth.2008.03.006 · Cited by 1,069 · see citing works
The bone marrow microenvironment at single-cell resolution
Tikhonova, A. N., Dolgalev, I., Hu, H., Sivaraj, K. K., Hoxha, E., Cuesta-Domínguez, Á., Pinho, S., Akhmetzyanova, I., Gao, J., Witkowski, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1104-8 · Cited by 936 · see citing works
Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection
Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C., & Goodell, M. A. (2010) · Nature · doi:10.1038/nature09135 · Cited by 877 · see citing works
Manz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855 · see citing works
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015) · Nature · doi:10.1038/nature15252 · Cited by 807 · see citing works
Winkler, I. G., Sims, N. A., Pettit, A. R., Barbier, V., Nowlan, B., Helwani, F., Poulton, I. J., van Rooijen, N., Alexander, K. A., Raggatt, L. J., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253534 · Cited by 801 · see citing works
Mesenchymal stromal cells: new directions
Keating, A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.015 · Cited by 778 · see citing works
Guidelines for the diagnosis and management of adult aplastic anaemia
Killick, S. B., Bown, N., Cavenagh, J., Dokal, I., Foukaneli, T., Hill, A., Hillmen, P., Ireland, R., Kulasekararaj, A., Mufti, G., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13853 · Cited by 749 · see citing works
Expression and function of c-kit in hemopoietic progenitor cells.
Ogawa, M., Matsuzaki, Y., Nishikawa, S., Hayashi, S., Kunisada, T., Sudo, T., Kina, T., Nakauchi, H., & Nishikawa, S. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.1.63 · Cited by 744 · see citing works
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand‐Rosenberg, S., & Srikrishna, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4666 · Cited by 722 · see citing works
Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654 · see citing works
Schepers, K., Pietras, E. M., Reynaud, D., Flach, J., Binnewies, M., Garg, T., Wagers, A. J., Hsiao, E. C., & Passegué, E. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.009 · Cited by 614 · see citing works
Erythroblastic islands: niches for erythropoiesis
Chasis, J. A., & Mohandas, N. (2008) · Blood · doi:10.1182/blood-2008-03-077883 · Cited by 506 · see citing works
Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462 · see citing works
Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms
Arranz, L., Sánchez-Aguilera, A., Martín-Pérez, D., Isern, J., Langa, X., Tzankov, A., Lundberg, P., Muntión, S., Tzeng, Y.-S., Lai, D.-M., et al. (2014) · Nature · doi:10.1038/nature13383 · Cited by 444 · see citing works
Mesenchymal stem cells in fibrotic disease
El Agha, E., Kramann, R., Schneider, R. K., Li, X., Seeger, W., Humphreys, B. D., & Bellusci, S. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.011 · Cited by 430 · cited 2× · see citing works
“Studies focusing on different myeloid diseases and also different niche cells were able to mechanistically elucidate how malignant, mutated hematopoietic cells and also proinflammatory cytokines activate distinct subsets of stromal cells in the BM, increase their secretory activity, and influence their reduced hematop…”
BackgroundSelf-citationAwakening dormant haematopoietic stem cells
Trumpp, A., Essers, M. A. G., & Wilson, A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2726 · Cited by 420 · see citing works
Inflammation: a key regulator of hematopoietic stem cell fate in health and disease
Pietras, E. M. (2017) · Blood · doi:10.1182/blood-2017-06-780882 · Cited by 417 · see citing works
Cellular and molecular basis for the regulation of inflammation by TGF-
Yoshimura, A., Wakabayashi, Y., & Mori, T. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq043 · Cited by 394 · see citing works
Metz, R. A., Rust, S., DuHadaway, J. B., Mautino, M. R., Munn, D. H., Vahanian, N. N., Link, C. J., & Prendergast, G. C. (2012) · OncoImmunology · doi:10.4161/onci.21716 · Cited by 389 · see citing works
Hanoun, M., Zhang, D., Mizoguchi, T., Pinho, S., Pierce, H., Kunisaki, Y., Lacombe, J., Armstrong, S. A., Dührsen, U., & Frenette, P. S. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.06.020 · Cited by 381 · see citing works
Broudy, V. C., Kaushansky, K., Segal, G. M., Harlan, J. M., & Adamson, J. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7467 · Cited by 373 · see citing works
Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment
Kovtonyuk, L. V., Fritsch, K., Feng, X., Manz, M. G., & Takizawa, H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00502 · Cited by 371 · see citing works
Ara, T., Tokoyoda, K., Sugiyama, T., Egawa, T., Kawabata, K., & Nagasawa, T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00201-2 · Cited by 369 · see citing works
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 356 · see citing works
Zambetti, N. A., Ping, Z., Chen, S., Kenswil, K. J. G., Mylona, M. A., Sanders, M. A., Hoogenboezem, R. M., Bindels, E. M. J., Adisty, M. N., Van Strien, P. M. H., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.021 · Cited by 342 · see citing works
Reynaud, D., Pietras, E., Barry-Holson, K., Mir, A., Binnewies, M., Jeanne, M., Sala-Torra, O., Radich, J. P., & Passegué, E. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.012 · Cited by 335 · see citing works
Zoumbos, N. C., Gascon, P., Djeu, J. Y., & Young, N. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.188 · Cited by 330 · see citing works
Suppression of antigen presentation by IL-10
Mittal, S. K., & Roche, P. A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.009 · Cited by 320 · see citing works
Induction of myelodysplasia by myeloid-derived suppressor cells
Chen, X., Eksioglu, E. A., Zhou, J., Zhang, L., Djeu, J., Fortenbery, N., Epling-Burnette, P., Van Bijnen, S., Dolstra, H., Cannon, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67580 · Cited by 316 · see citing works
Anaemia in kidney disease: harnessing hypoxia responses for therapy
Koury, M. J., & Haase, V. H. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.82 · Cited by 313 · see citing works
Arinobu, Y., Mizuno, S.-I., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf, T., Mayfield, R., Chan, S., Kastner, P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.004 · Cited by 309 · see citing works
Regulation of hematopoietic stem cells by bone marrow stromal cells
Anthony, B. A., & Link, D. C. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.10.002 · Cited by 301 · see citing works
Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing
Ergen, A. V., Boles, N. C., & Goodell, M. A. (2012) · Blood · doi:10.1182/blood-2011-11-391730 · Cited by 280 · see citing works
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
Sallman, D. A., & List, A. (2019) · Blood · doi:10.1182/blood-2018-10-844654 · Cited by 273 · see citing works
Carey, A., Edwards, D. K., Eide, C. A., Newell, L., Traer, E., Medeiros, B. C., Pollyea, D. A., Deininger, M. W., Collins, R. H., Tyner, J. W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.018 · Cited by 270 · see citing works
Schneider, R. K., Mullally, A., Dugourd, A. J. F., Peisker, F., Hoogenboezem, R. M., van Strien, P. M. H., Bindels, E. M., Heckl, D., Büsche, G., Fleck, D., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.03.008 · Cited by 270 · see citing works
Self-citationTRAIL/Apo-2-ligand-induced apoptosis in human T cells
Jeremias, I., Herr, I., Böhler, T., & Debatin, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01 · Cited by 265 · see citing works
Endothelial cells translate pathogen signals into G-CSF–driven emergency granulopoiesis
Boettcher, S., Gerosa, R. C., Radpour, R., Bauer, J., Ampenberger, F., Heikenwälder, M. F., Köpf, M., & Manz, M. G. (2014) · Blood · doi:10.1182/blood-2014-04-570762 · Cited by 260 · see citing works
Winkler, I. G., Barbier, V., Wadley, R. B., Zannettino, A. C. W., Williams, S., & Lévesque, J.-P. (2010) · Blood · doi:10.1182/blood-2009-07-233437 · Cited by 246 · see citing works
Biasco, L., Pellin, D., Scala, S., Dionisio, F., Basso-Ricci, L., Leonardelli, L., Scaramuzza, S., Baricordi, C., Ferrua, F., Cicalese, M. P., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.04.016 · Cited by 243 · see citing works
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Gañán-Gómez, I., Wei, Y., Starczynowski, D. T., Colla, S., Yang, H., Cabrero-Calvo, M., Bohannan, Z. S., Verma, A., Steidl, U., & Garcia-Manero, G. (2015) · Leukemia · doi:10.1038/leu.2015.69 · Cited by 236 · see citing works
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Schneider, R. K., Schenone, M., Ferreira, M. S. V., Kramann, R., Joyce, C. E., Hartigan, C. R., Beier, F., Brümmendorf, T. H., Germing, U., Platzbecker, U., et al. (2016) · Nature Medicine · doi:10.1038/nm.4047 · Cited by 236 · see citing works
Self-citationPrestipino, A., Emhardt, A. J., Aumann, K., O’Sullivan, D., Gorantla, S. P., Duquesne, S., Melchinger, W., Braun, L. M., Vučković, S., Boerries, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7729 · Cited by 231 · see citing works
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
Solomou, E. E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A. J., & Young, N. S. (2007) · Blood · doi:10.1182/blood-2007-01-066258 · Cited by 225 · see citing works
Impact of interferon-γ on hematopoiesis
de Bruin, A. M., Voermans, C., & Nolte, M. A. (2014) · Blood · doi:10.1182/blood-2014-04-568451 · Cited by 215 · see citing works
Schürch, C. M., Riether, C., & Ochsenbein, A. F. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.01.002 · Cited by 213 · see citing works
Selleri, C., Maciejewski, J., Sato, T., & Young, N. (1996) · Blood · doi:10.1182/blood.v87.10.4149.bloodjournal87104149 · Cited by 209 · see citing works
Barrett, J., Saunthararajah, Y., & Molldrem, J. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90027-1 · Cited by 207 · see citing works
Sieff, C. A., Tsai, S., & Faller, D. V. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112806 · Cited by 205 · see citing works
RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis
Strauss, L., Sangaletti, S., Consonni, F. M., Szebeni, G. J., Morlacchi, S., Totaro, M. G., Porta, C., Anselmo, A., Tartari, S., Doni, A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.006 · Cited by 204 · see citing works
Myeloid suppressor cells in cancer and autoimmunity
Sica, A., & Massarotti, M. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.010 · Cited by 201 · see citing works
Role of nitric oxide in the regulation of T cell functions
Niedbała, W., Cai, B., & Liew, F. Y. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058446 · Cited by 181 · see citing works
IFNγ induces monopoiesis and inhibits neutrophil development during inflammation
de Bruin, A. M., Libregts, S. F., Valkhof, M., Boon, L., Touw, I. P., & Nolte, M. A. (2012) · Blood · doi:10.1182/blood-2011-07-367706 · Cited by 146 · see citing works
Macciò, A., Madeddu, C., Massa, D., Mudu, M. C., Lusso, M. R., Gramignano, G., Serpe, R., Melis, G. B., & Mantovani, G. (2005) · Blood · doi:10.1182/blood-2005-01-0160 · Cited by 144 · see citing works
DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
Huang, J., Xie, Y., Sun, X., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.004 · Cited by 144 · see citing works
New concepts on the immune modulation mediated by mesenchymal stem cells
Bunnell, B. A., Betancourt, A. M., & Sullivan, D. E. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt34 · Cited by 132 · see citing works
Tuljapurkar, S. R., McGuire, T. R., Brusnahan, S. K., Jackson, J. D., Garvin, K. L., Kessinger, M. A., Lane, J. T., O’ Kane, B. J., & Sharp, J. G. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01423.x · Cited by 129 · see citing works
Rambaldi, A., Torcia, M., Bettoni, S., Vannier, E., Barbui, T., Shaw, A., Dinarello, C., & Cozzolino, F. (1991) · Blood · doi:10.1182/blood.v78.12.3248.3248 · Cited by 129 · see citing works
PU.1 determines the self-renewal capacity of erythroid progenitor cells
Back, J., Dierich, A., Bronn, C., Kastner, P., & Chan, S. (2004) · Blood · doi:10.1182/blood-2003-11-4089 · Cited by 123 · see citing works
Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration
Martino, M. M., Maruyama, K., Kuhn, G. A., Satoh, T. K., Takeuchi, O., Müller, R., & Akira, S. (2016) · Nature Communications · doi:10.1038/ncomms11051 · Cited by 123 · see citing works
Clinical significance of B7-H1(PD-L1)expression in human acute leukemia
Chen, X., Liu, S., Wang, L., Zhang, W., Ji, Y., & Ma, X. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.5.5689 · Cited by 122 · see citing works
Three-dimensional model of bone marrow
Mohandas, N., & Prenant, M. (1978) · Blood · doi:10.1182/blood.v51.4.633.633 · Cited by 121 · see citing works
Targeting the immune microenvironment in acute myeloid leukemia: a focus on T cell immunity
Lamble, A. J., & Lind, E. F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00213 · Cited by 119 · see citing works
Warr, M. R., Pietras, E. M., & Passegué, E. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.145 · Cited by 112 · see citing works
Liu, Y., Yu, Y., Yang, S., Zeng, B., Zhang, Z., Jiao, G., Zhang, Y., Cai, L., & Yang, R. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0591-5 · Cited by 104 · see citing works
The role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease
Morales-Mantilla, D. E., & King, K. Y. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0139-3 · Cited by 99 · see citing works
Chen, J., Feng, X., Desierto, M. J., Keyvanfar, K., & Young, N. S. (2015) · Blood · doi:10.1182/blood-2015-06-652453 · Cited by 97 · see citing works
Multiple members of the TNF superfamily contribute to IFN-γ-mediated inhibition of erythropoiesis
Felli, N., Pedini, F., Zeuner, A., Petrucci, E., Testa, U., Conticello, C., Biffoni, M., Di Cataldo, A., Winkles, J. A., Peschle, C., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1464 · Cited by 96 · see citing works
Giudice, V., Feng, X., Lin, Z., Hu, W., Zhang, F., Qiao, W., Ibanez, M. D. P. F., Rios, O., & Young, N. S. (2018) · Haematologica · doi:10.3324/haematol.2017.176701 · Cited by 92 · see citing works
Gargiulo, L., Papaioannou, M., Sica, M., Talini, G., Chaidos, A., Richichi, B., Nikolaev, A. V., Nativi, C., Layton, M., de la Fuente, J., et al. (2013) · Blood · doi:10.1182/blood-2012-11-469353 · Cited by 89 · see citing works
Chen, S., Zambetti, N. A., Bindels, E. M. J., Kenswill, K., Mylona, A. M., Adisty, N. M., Hoogenboezem, R. M., Sanders, M. A., Cremers, E. M. P., Westers, T. M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.91 · Cited by 79 · see citing works
Eksioglu, E. A., Chen, X., Heider, K.-H., Rueter, B., McGraw, K. L., Basiorka, A. A., Wei, M., Burnette, A., Cheng, P., Lancet, J., et al. (2017) · Leukemia · doi:10.1038/leu.2017.21 · Cited by 66 · see citing works
Kramann, R., & Schneider, R. K. (2018) · Blood · doi:10.1182/blood-2018-02-834820 · Cited by 62 · see citing works
Self-citationGargiulo, L., Lastraioli, S., Cerruti, G., Serra, M., Loiacono, F., Zupo, S., Luzzatto, L., & Notaro, R. (2007) · Blood · doi:10.1182/blood-2006-10-052381 · Cited by 56 · see citing works
Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment
Perlin, J. R., Sporrij, A., & Zon, L. I. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1559-8 · Cited by 52 · see citing works
Ribezzo, F., Snoeren, I. A. M., Ziegler, S., Stoelben, J., Olofsen, P. A., Henic, A., Ferreira, M. V., Chen, S., Stalmann, U. S. A., Buesche, G., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0350-3 · Cited by 51 · see citing works
Self-citationNeural Crossroads in the Hematopoietic Stem Cell Niche
Agarwala, S., & Tamplin, O. J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.05.003 · Cited by 46 · see citing works
Bone marrow immunity and myelodysplasia
Lambert, C., Wu, Y., & Aanei, C. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00172 · Cited by 42 · see citing works
IFN-α wakes up sleeping hematopoietic stem cells
Passegue, E. A., & Ernst, P. (2009) · Nature Medicine · doi:10.1038/nm0609-612 · Cited by 39 · see citing works
Ishihara, J., Umemoto, T., Yamato, M., Shiratsuchi, Y., Takaki, S., Petrich, B. G., Nakauchi, H., Eto, K., Kitamura, T., & Okano, T. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1534-x · Cited by 28 · see citing works
Gleitz, H. F., Kramann, R., & Schneider, R. K. (2018) · The Journal of Pathology · doi:10.1002/path.5078 · Cited by 23 · see citing works
Self-citationExpression level of IL-6 secreted by bone marrow stromal cells in mice with aplastic anemia
Chen, Y. F., Wu, Z. M., Xie, C., Bai, S., & Zhao, L. D. (2013) · ISRN Hematology · doi:10.1155/2013/986219 · Cited by 21 · see citing works
Spyridonidis, A., Küttler, T., Wäsch, R., Samek, E., Waterhouse, M., Behringer, D., Bertz, H., & Finke, J. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.213 · Cited by 18 · see citing works
Michelozzi, I. M., Pievani, A., Pagni, F., Antolini, L., Verna, M., Corti, P., Rovelli, A., Riminucci, M., Dazzi, F., Biondi, A., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14234 · Cited by 16 · see citing works
Verovskaya, E., Calero-Nieto, F., Reynaud, D., Zhang, S. Y., Herault, A., Bakker, S., Pietras, E., Svendsen, A. F., Wang, X., Kinston, S., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.06.048 · Cited by 4 · cited 2× · see citing works
“Recent single-cell studies on niche cells in young and aged mice demonstrated activation of inflammatory response programs, changes in osteoblastic differentiation, and also metabolism with age, in particular through upregulation of IL1a/b.(47) The pharmacological inhibition of IL-1 signaling resulted in recovery of t…”
BackgroundRisitano, A. M. (2017) · Blood · doi:10.1182/blood-2017-03-771493 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rejeski, K., Jain, M. D., Shah, N. N., Perales, M., & Subklewe, M. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00077-2 · Cited by 130 · see citing works
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115 · see citing works
Clonal hematopoiesis, somatic mosaicism, and age-associated disease
Evans, M. A., & Walsh, K. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2022 · Cited by 105 · see citing works
Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation
Nunez, S. G., Rabelo, S. P., Subotic, N., Caruso, J. W., & Knezevic, N. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209994 · Cited by 138 · see citing works
“Elevated cortisol and catecholamines act on bone marrow, leading to an expansion of myeloid lineages at the expense of lymphoid progenitors, thereby creating a microenvironment that favors autoimmunity [79].”
Ainciburu, M., Ezponda, T., Berastegui, N., Piérola, A. A., Vilas‐Zornoza, A., Martín‐Úriz, P. S., Alignani, D., Lamo-Espinosa, J. M., San-Julián, M., Jiménez, T., et al. (2023) · eLife · doi:10.7554/elife.79363 · Cited by 64 · see citing works
Inflammation, Aging and Hematopoiesis: A Complex Relationship
Bousounis, P., Bergo, V., & Trompouki, E. (2021) · Cells · doi:10.3390/cells10061386 · Cited by 58 · see citing works
Yao, J., Liu, J., He, Y., Lin, X., Xu, Z., Lin, X., Liu, N., & Kai, G. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116533 · Cited by 46 · see citing works
Gleitz, H. F. E., Benabid, A., & Schneider, R. K. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000669 · Cited by 41 · see citing works
Self-citationIncreased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles
Swart, L. E., Fens, M. H. A. M., van Oort, A. T., Waranecki, P., Casimiro, L. D. M., Tuk, D., Hendriksen, M., van den Brink, L. M., Schweighart, E. K., Seinen, C. W., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061603 · Cited by 32 · see citing works
Precision medicine in myeloid malignancies
Westermann, J., & Bullinger, L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.034 · Cited by 29 · see citing works
Farber, M., Chen, Y., Arnold, L., Möllmann, M., Boog-Whiteside, E., Lin, Y.-A., Reinhardt, H. C., Dührsen, U., & Hanoun, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01300-8 · Cited by 27 · see citing works
Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy
Ferrer, A. I., Roser, C. T., El-Far, M. H., Savanur, V. H., Eljarrah, A., Gergues, M., Kra, J., Etchegaray, J., & Rameshwar, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.026 · Cited by 29 · see citing works
Jann, J.-C., Mossner, M., Riabov, V., Altrock, E., Schmitt, N., Flach, J., Xu, Q., Nowak, V., Obländer, J., Palme, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26424-3 · Cited by 25 · see citing works
Zheng, X., Wang, Q., Xie, Z., & Li, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111313 · Cited by 23 · see citing works
Higher red cell distribution width and poorer hospitalization‐related outcomes in elderly patients
Kim, K. M., Nerlekar, R., Tranah, G. J., Browner, W. S., & Cummings, S. R. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17819 · Cited by 23 · see citing works
Wang, J., Xin, Y., Dong, Z., Li, S., & Yang, G. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112974 · Cited by 21 · see citing works
Vascular Regulation of Hematopoietic Stem Cell Homeostasis, Regeneration, and Aging
Ramalingam, P., Butler, J. M., & Poulos, M. G. (2021) · Current Stem Cell Reports · doi:10.1007/s40778-021-00198-2 · Cited by 18 · see citing works
Minciacchi, V. R., Karantanou, C., Bravo, J., Pereira, R. S., Zanetti, C., Krack, T., Kumar, R., Bankov, K., Hartmann, S., Huntly, B. J. P., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024012867 · Cited by 18 · see citing works
Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
Burns, S. S., & Kapur, R. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.07.008 · Cited by 18 · see citing works
Metabolic reprogramming and immune regulation in acute myeloid leukemia
Hao, X., Fan, C., Yan, L., Jianati, R., Guo, Y., Zhou, X., Zhu, G., Zhang, Y., Zheng, C., Zhang, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1655005 · Cited by 16 · see citing works
Sabah, R., Saadi, S., Shahar-Gabay, T., Gerassy-Vainberg, S., Yehudai‐Resheff, S., & Zuckerman, T. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01231-z · Cited by 15 · see citing works
Hasselbalch, H. C., Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Larsen, M. K., Holmström, M. O., Andersen, M. H., Jensen, C., Karsdal, M. A., et al. (2023) · Cancers · doi:10.3390/cancers15174323 · Cited by 14 · see citing works
CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation
Huang, M., Zeng, K., Lyu, M.-A., Masárová, L., Sadeghi, T., Flowers, C. R., & Parmar, S. (2024) · iScience · doi:10.1016/j.isci.2024.110830 · Cited by 12 · see citing works
ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis
de Oliveira, R. T. G., Cordeiro, J. V. A., Vitoriano, B. F., Melo, M. M. D. L., Sampaio, L. R., Borges, D. D. P., Magalhães, S. M. M., & Pinheiro, R. F. (2021) · Medical Oncology · doi:10.1007/s12032-021-01466-1 · Cited by 12 · see citing works
Giallongo, C., Dulcamare, I., Giallongo, S., Duminuco, A., Pieragostino, D., Cufaro, M. C., Amorini, A. M., Lazzarino, G., Romano, A., Parrinello, N. L., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06197-x · Cited by 11 · see citing works
Bone marrow macrophages are involved in the ineffective hematopoiesis of myelodysplastic syndromes
Xing, T., Yao, W., Zhao, H., Wang, J., Zhang, Y., Lv, M., Xu, L., Zhang, X., Huang, X., & Kong, Y. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31129 · Cited by 10 · see citing works
Micro‐environment alterations through time leading to myeloid malignancies
Nyamondo, K., & Wheadon, H. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15924 · Cited by 10 · see citing works
Acquired and hereditary bone marrow failure: A mitochondrial perspective
Nasr, W., & Filippi, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1048746 · Cited by 9 · see citing works
Williams, C. M. D., Noll, J. E., Bradey, A. L., Duggan, J., Wilczek, V. J., Masavuli, M. G., Grubor‐Bauk, B., Panagopoulos, R. A., Hewett, D. R., Mrozik, K. M., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.19102 · Cited by 9 · see citing works
Gabay, T. S., Chapal-Ilani, N., Moskovitz, Y., Biezuner, T., Oron, B., Brilon, Y., Fridman‐Dror, A., Sabah, R., Balicer, R. D., Tanay, A., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.242347 · Cited by 8 · see citing works
Özdemir, C., Muratoğlu, B., Özel, B. N., Alpdundar, E., Tonyalı, G., Ünal, Ş., & Uçkan, D. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01087-0 · Cited by 8 · see citing works
Burns, S. S., & Kapur, R. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.06.021 · Cited by 8 · see citing works
Kim, E., Kim, J.-E., Chung, S.-H., Park, J. E., Yoon, D., Min, H.-J., Sung, Y., Lee, S. B., Kim, S. W., & Chang, E. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01226-w · Cited by 7 · see citing works
Gu, Y., Xia, J., Guo, Y., Tao, L., Zhang, G., & Xu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-01711-x · Cited by 8 · see citing works
Wan, D., Ai, S., Ouyang, H., & Cheng, L. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00605-y · Cited by 7 · see citing works
Udenze, D., Trus, I., Lipsit, S., Napper, S., & Karniychuk, U. U. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2147021 · Cited by 7 · see citing works
Artamonov, M. Y., Sokov, E. L., Kornilova, L. E., & Minenko, I. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083876 · Cited by 6 · see citing works
Zhang, G., Zhu, X., Yang, F., Li, J., Leng, X., Mo, C., Li, L., & Wang, Y. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2063344 · Cited by 6 · see citing works
Abohashem, S., Aldosoky, W., Abbasi, T. A., Dar, T. A., Rollings, R. C., Tung, B., Hammad, B., Saeed, F. U., Ali, A., Takx, R. A. P., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156427 · Cited by 5 · see citing works
Gorur, V., Kranc, K. R., Ganuza, M., & Telfer, P. T. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101137 · Cited by 6 · see citing works
Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes
Schmied, L., Olofsen, P. A., Lundberg, P., Tzankov, A., Kleber, M., Halter, J. P., Uhr, M., Valk, P. J. M., Touw, I. P., Passweg, J. R., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001541 · Cited by 5 · see citing works
Banjanin, B., & Schneider, R. K. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.618308 · Cited by 5 · see citing works
Self-citationMobasheri, A., Henriques, J., & Collins, J. E. (2025) · Osteoarthritis Imaging · doi:10.1016/j.ostima.2025.100374 · Cited by 4 · see citing works
Hong, Y., Liu, X., Mao, W., Ma, B., Chen, H., Zhang, X., & Li, D. (2025) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.38016 · Cited by 4 · see citing works
A human pathophysiological 3D-bone marrow model reveals immune and stromal cell heterogeneity
Giannini, M., Campione, G., Torcq, L., Donadelli, S., Bencheikh, M., Bounaud, S., Jeanpierre, S., Geistlich, K., Maguer‐Satta, V., Lefort, S., et al. (2026) · Communications Biology · doi:10.1038/s42003-025-09433-6 · Cited by 4 · see citing works
Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche
Rasheed, A., Robichaud, S., Dennison, T., Nguyen, M.-A., Geoffrion, M., Reed, J. N., Wyatt, H., Marouf, Y., Baxi, A., Lee, R. G., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00470-8 · Cited by 4 · see citing works
Aru, B., Soltani, M., Pehlivanoğlu, C., Gürlü, E., Ganjalıkhani-Hakemi, M., & Demirel, G. Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.789728 · Cited by 4 · see citing works
Gut Microbiota Composition Correlates with Disease Severity in Myelodysplastic Syndrome
Riello, G. B. C., da Silva, P. M., Oliveira, F. A. D. S., de Oliveira, R. T. G., da Silva, F. E. R., França, I. G. D. F., Miyajima, F., Melo, V. M. M., Pinheiro, R. F., & Macêdo, D. S. (2024) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v18i2.15377 · Cited by 4 · see citing works
Belmonte, M., Cabrera-Cosme, L., Øbro, N. F., Li, J., Grinfeld, J., Milek, J., Bennett, E., Irvine, M., Shepherd, M. S., Cull, A. H., et al. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104246 · Cited by 3 · see citing works
Basic Science of Resident Stem Cells
Fortier, L. A., & Lintz, M. (2020) · Operative Techniques in Sports Medicine · doi:10.1016/j.otsm.2020.150776 · Cited by 3 · see citing works
Circulating mitochondrial DNA is associated with anemia in newly diagnosed hematologic malignancies
Yue, L., Li, Y., Ma, R., Niu, J.-W., Cui, H., Sun, Y., Yun, Z., Zhuo, H., Wan, L., Li, S.-B., et al. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2133537 · Cited by 3 · see citing works
Clodronate liposomes may biases MSC differentiation toward adipogenesis through activation of NLRP3
Ding, S., Wang, Y., Liu, Z., Du, Y., Zhou, Y., Liu, Y., Sun, J., Li, Y., & Zeng, L. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2023.05.001 · Cited by 2 · see citing works
Inam, Z. S., Pan, M., Diab, Y., Schore, R. J., Vatsayan, A., & Cheng, J. (2024) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2024-0164-ra · Cited by 2 · see citing works
Pavel-Dinu, M., Viel, S., Selvaraj, S., Gastou, M., Feist, W. N., Perret, M., Rouvet, I., Nombel, A., Hacein‐Bey‐Abina, S., Bélot, A., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5090716/v1 · Cited by 2 · see citing works
Valsecchi, C., Croce, S., Maltese, A., Montagna, L., Lenta, E., Nevone, A., Girelli, M., Milani, P., Bosoni, T., Massa, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111523 · Cited by 1 · see citing works
Bone Marrow Lymphocytes’ Development and Dynamics
Rizk, S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002915 · Cited by 1 · see citing works
Ji, P., Wang, P., Li, Q., Gao, L., Xu, Y. L., Pan, H., Zhang, C., Li, J., Yao, J., & An, Q. (2024) · Animals · doi:10.3390/ani14233507 · Cited by 1 · see citing works
Berastegui, N., Ainciburu, M., Romero, J. P., Piérola, A. A., Philippe, C., Vilas‐Zornoza, A., Martin, P. S., Ordóñez, R., Alignani, D., Sarvide, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.08.459384 · Cited by 1 · see citing works
Yang, S. J., Wang, Z., & Lin, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620670 · Cited by 1 · see citing works
Zhang, G., Zhu, X., Yang, F., Li, J., Leng, X., Li, L., & Wang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-994223/v1
Lymphatic System - From Human Anatomy to Clinical Practice
Favero, G., & Facchetti, L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111139
Beyond the Marrow–Moving Toward a Systemic Perspective of Radiation-Induced Cytopenias
Browning, S. L., de Lourdes, M., Neparidze, N., & Robinson, T. J. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.11.100
Advances in Modern Medical Research on the Hematopoietic Effect of Qi and Blood Replenishing Drugs
段, 爽. (2025) · Medical Diagnosis · doi:10.12677/md.2025.151017
Ren, S., Wei, Y., Liu, W., Zhang, Y., Wang, Y., Yang, J. D., Liu, B., Shi, T., & Wei, J. (2025) · Cancer Medicine · doi:10.1002/cam4.70781
The impact of immature granulocytes on the outcome of patients with decompensated cirrhosis
Adamantou, M., Glaros, D., Michelis, E., Papageorgiou, A., Adamopoulou, E., Alevizou, A., Athanasiadis, M., Pergantina, E., GEORGAKOPOULOU, V. E., Lekakis, V., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70044
The Inflamed Bone Marrow Scenery Amongst the Symplegades of Ageing and Diseases
Zarro, P. R., Felice, S. D., Sabbieti, M. G., & Agas, D. (2025) · Advances in experimental medicine and biology · doi:10.1007/5584_2025_860
Li, K., Wu, R., Zhou, T., & Xiong, J. (2025) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2024.0207
Spinal Cord Injury Imprints a Glucocorticoid-Driven Failure State in Hematopoietic Stem CellsPreprint
Rodgers, K. A., Garfinkle, E. A. R., Kigerl, K. A., Adib, E. A., Mifflin, K. A., Hall, J. C. E., Kulkarni, R. S., Wang, C., Goda, C., Dias, A. C. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.05.680535
Pendse, S., Chavan, S., Kasherwal, V., Kale, V. P., & Vaidya, A. (2025) · Cell Biology International · doi:10.1002/cbin.70113
Kim, E.-Y., Kim, J.-E., Chung, S.-H., Park, J.-E., Yoon, D., Min, H.-J., Sung, Y., Lee, S. B., Kim, S. W., & Chang, E.-J. (2023) · Figshare · doi:10.6084/m9.figshare.23993355
Sabah, R., Saadi, S., Shahar-Gabay, T., Gerassy-Vainberg, S., Yehudai‐Resheff, S., & Zuckerman, T. (2024) · Figshare · doi:10.6084/m9.figshare.24286657
Sabah, R., Saadi, S., Shahar-Gabay, T., Gerassy-Vainberg, S., Yehudai‐Resheff, S., & Zuckerman, T. (2023) · Figshare · doi:10.6084/m9.figshare.24286498
Martínez, P. R., Díaz, E. S., Ibarra, F. S., Vázquez-Urrutia, J. R., García, J. D. J. G., Téllez‐Bañuelos, M. C., Castañeda‐Delgado, J. E., Reyes, K. S., & Ortiz‐Lazareno, P. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031511
Arslan, S., Erkurt, M. A., Kuku, İ., Kaya, E., Berber, İ., Sarıcı, A., & Kaya, A. (2026) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2026.104433
Каленик, О. А., Жаркова, Е. Ю., Savich, T. V., Иваницкая, Т. А., Саридзе, Э. Х., & Конопля, Н. Е. (2026) · Евразийский онкологический журнал · doi:10.34883/pi.2026.14.2.006
Saxena, P., Upadhyaya, A., Rai, B., Srivastava, J., Gupta, R., Yadav, S., & Chaturvedi, C. P. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12337-1
Hurley, K., Kaul, R., Yadav, S., Rijal, D., Sam, L., Bhan, A., Hamra, R. E., Ariana, A., Mahdi, A., Brandt, W., et al. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01451-6
The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to clinical intervention
Ye, C., Fu, S., Li, J., Xue, J., & Li, J. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101349
Inflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum
Beesetti, S. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl50689
Karniychuk, U. U. (2026) · Veterinary Sciences · doi:10.3390/vetsci13090983
Cradle of rebellion: the relationship between bone marrow microenvironment and autoimmune diseases
Wang, Q., Cheng, J., Gu, Z., & Chen, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1760577
- Authors
- Leimkühler, N. B., & Schneider, R. K.
- Affiliations
- Erasmus MC Cancer Institute (NL)
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2019-12-06
- Volume
- 2019
- Issue
- 1
- Pages
- 294-302
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- PMC
- PMC6913454
- OpenAlex
- W2992281429
- Cited by
- 82
- References
- 100
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 9 · 2021: 14 · 2020: 6
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hematology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- European Hematology Association
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Blood disorders and treatments
- Keywords
- bone marrow microenvironment, hematopoietic stem and progenitor cells, chronic inflammation, hematopoietic niche, hematopoiesis, aging, low-grade inflammation, age-related clonal hematopoiesis, hematologic malignancies, clonal selection, DNA damage, leukemia
- MeSH terms
- Aging, Animals, Bone Marrow, Hematopoiesis, Humans, Inflammation, Models, Biological, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review